Form 4 for TMO Thermo Fisher Scientific
Accepted 2026-03-02 00:00:00 ET · period of report 2026-02-28 · accession 0000097745-26-000051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-02 | 2026-02-28 | TMO | Britt Lisa P. | SVP, Chief HR Off | F - Tax | $521.11 | -348.08 | 14.8K | -2% | -$181.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-28 | F | D | 262.67 | $521.11 | 14,869.56 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-28 | F | D | 85.41 | $521.11 | 14,784.15 | D | — | — |